Abstract:
Abstract.
Background. The Institute of Emergency Medicine from
Chisinau has joined the Registry of Stroke Care Quality
(RES-Q) in 2017.
Material and Methods. We have analyzed the stroke
patients’ data introduced in RES-Q between 20172022.
Baseline characteristics, stroke-related factors, processes of
care, and discharge destination were examined.
Results. Data were available for 489 stroke patients.
The proportion of patients with ischemic strokes receiving thrombolysis therapy has substantially increased from
2.78% in 2017 to 20% in 2022, and the median door-toneedle time decreased from 85 minutes (2017) to 48 minutes (2021). Thrombectomy began to be performed in 2018
at the Institute of Emergency Medicine, the rate of stroke
patients receiving thrombectomy increased from 3.23% in
2019 to 10% in 2022, median door-to-groin time decreased
from 228.5 minutes in 2019 to 102 minutes in 2021. More
than 80% of patients received secondary prevention therapies that were level-1 evidence-based processes of care:
antihypertensive agents (89.47% – 98.44%), antiplatelet
drugs (81.63% – 100%), anticoagulants for patients with
atrial fibrillation (25% in 2018 vs 100% in 2021), but cholesterol-lowering medication was prescribed to approximately a half of the participants (44.23% – 60.0%). There
were more deaths in the pandemic years (36.67% in 2021
vs 18.99% in 2017).
Conclusion. Most hospitalized stroke patients admitted to the Institute of Emergency Medicine received evidence-based care. The COVID-19 pandemic has left its mark
on the number of stroke hospitalizations, but the quality of
in-hospital stroke care was not dramatically affected.
